Correlative data suggests that normal levels of EPCs neutralize the effects of diabetes on vascular tissues.

This paper investigates the correlation between the lack of vascular complications in type 1 diabetes patients with the presence of endothelial progenitor cells (EPCs) and circulating progenitor cells (CPCs) in their blood.

Normal levels of EPC and CPC in patients Joslin Medalist Study, unlike other groups with diabetes, support the idea that these cells contribute to neutralize the adverse effects on vascular tissues of diabetes patients.